Effect of food on capsule and granule formulations of selumetinib.
Sign Up to like & getrecommendations! Published in 2022 at "Clinical and translational science"
DOI: 10.1111/cts.13209
Abstract: Selumetinib is an oral, potent, and highly selective allosteric MEK1/2 inhibitor approved for the treatment of pediatric patients (aged ≤2 years) with neurofibromatosis type 1 who have symptomatic, inoperable plexiform neurofibromas. A granule formulation of selumetinib… read more here.
Keywords: effect food; granule formulations; capsule granule; selumetinib ... See more keywords